EN PL

FDA: Guidance for Industry: ANDA Submissions - Refuse-to-Receive Standards

03.10.2013
This guidance is intended to assist sponsors preparing to submit to the Food and Drug Administration (FDA) abbreviated new drug applications (ANDAs) and prior approval supplements (PASs) to ANDAs for which the applicant is seeking approval of a new strength of he drug product.